YOLFTbeta
Evolent Health Inc

Evolent Health Inc

EVH · NYSE · Healthcare / Health Information Services

4.90USD+0.13 (+2.73%)

Price History

Full chart

Market Stats

Previous Close4.77
Open4.74
Day Range4.63 – 4.90
52-Week Range2.10 – 8.98
Volume1.24M
Market Cap397.97M
P/E (TTM)0.00
Forward P/E8.62
EPS-4.37
Dividend Yield0.00%
Beta0.84
50-Day Avg4.28
200-Day Avg3.85

About

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Seth Barrie Blackley
  • Employees4.20K
  • Headquarters1812 N. Moore Street, Arlington, VA, United States, 22209, USA
  • Websitehttps://www.evolent.com

Leadership

  • Mr. Seth Barrie BlackleyCo-Founder, CEO & Director · b. 1979
  • Mr. Dan McCarthyPresident · b. 1985
  • Mr. Jonathan David Weinberg J.D.Chief Legal Officer, General Counsel & Secretary · b. 1968
  • Mr. John Paul JohnsonChief Strategy Officer · b. 1984
  • Mr. Mario Marques RamosChief Financial Officer · b. 1972
  • Ms. Katie DiPerna CookChief Operating Officer
  • Mr. Aammaad ShamsChief Accounting Officer · b. 1984
  • Mr. Robert CruzChief Technology Officer
  • Ms. Jessica WhiteChief Information Officer
  • Dr. John Tam M.D.Chief Growth Officer

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue8.35M25.67M100.89M96.88M254.19M434.95M627.06M687.12M924.64M907.96M1.35B1.96B2.55B1.88B
Growth (%)-+207.58%+293.00%-3.97%+162.38%+71.11%+44.17%+9.58%+34.57%-1.80%+48.91%+45.26%+30.09%-26.56%
Cost of Revenue11.27M30.02M73.12M57.40M155.18M269.35M327.82M513.03M696.58M657.55M1.04B1.50B2.19B1.59B
Gross Profit-2.93M-4.35M27.77M39.48M99.01M165.60M299.24M174.09M228.06M250.41M316.58M460.47M367.35M284.03M
Gross Margin-35.08%-16.93%27.52%40.75%38.95%38.07%47.72%25.34%24.66%27.58%23.42%23.45%14.38%15.14%
Operating Expense16.69M16.81M53.01M82.45M336.43M238.44M346.72M482.97M490.90M292.82M312.94M531.68M407.84M288.47M
Operating Income-19.62M-21.16M-25.25M-42.97M-237.42M-72.84M-47.48M-308.88M-262.85M-42.41M3.64M-71.21M-40.48M-4.43M
Operating Margin-235.07%-82.41%-25.02%-44.36%-93.40%-16.75%-7.57%-44.95%-28.43%-4.67%0.27%-3.63%-1.58%-0.24%
EBITDA-19.50M-20.35M-25.25M-31.51M-220.31M-40.40M-4.15M-254.52M-240.74M55.66M43.75M-24.79M84.85M-361.31M
EBITDA Margin-233.70%-79.26%-25.02%-32.52%-86.67%-9.29%-0.66%-37.04%-26.04%6.13%3.24%-1.26%3.32%-19.26%
Net Income-19.26M20.02M-25.25M332.49M-159.74M-60.66M-52.66M-301.97M-334.25M-37.60M-19.16M-113.04M-61.62M-534.51M
Net Income Margin-230.81%78.00%-25.02%343.21%-62.84%-13.95%-8.40%-43.95%-36.15%-4.14%-1.42%-5.76%-2.41%-28.49%
R&D-2.00M4.00M5.80M11.10M17.20M18.20M19.80M24.30M26.50M27.00M26.70M--
R&D as % of Total Revenue-7.79%3.96%5.99%4.37%3.95%2.90%2.88%2.63%2.92%2.00%1.36%--
Interest Expense-820.00K0293.00K723.00K3.64M5.48M14.55M28.32M25.43M15.57M54.20M24.72M57.47M
Interest Expense % of Total Revenue-3.19%0.00%0.30%0.28%0.84%0.87%2.12%3.06%2.80%1.15%2.76%0.97%3.06%

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.30M101.97M38.28M1.02B1.20B1.31B1.72B1.50B1.47B1.42B1.82B2.68B2.54B1.90B
Total Liabilities11.10M70.93M40.35M80.94M287.73M266.39M532.92M568.97M854.84M725.83M957.88M1.61B1.54B1.48B
Total Equity5.20M31.04M-2.07M649.34M912.11M1.05B1.19B922.36M619.60M693.63M859.42M1.07B1.00B415.19M
Cash5.25M67.89M15.13M145.73M134.56M238.43M228.32M101.01M333.38M266.28M188.20M192.82M104.20M151.86M
Total Debt----120.28M121.39M343.64M368.79M359.78M280.47M476.12M644.80M713.67M989.70M
Net Debt-5.25M-67.89M--145.73M-14.28M-117.04M-7.28M267.79M26.41M14.19M287.92M451.97M609.47M837.84M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-12.77M-13.63M-75.09M-19.83M-35.51M-27.96M-20.65M-42.65M-16.23M38.75M-11.55M142.58M18.77M38.84M
Investing Cash Flow-3.78M-25.91M-3.58M-43.68M-97.80M-12.27M-160.38M-181.63M261.07M-15.79M-259.12M-415.54M-62.93M-233.00K
Financing Cash Flow4.50M34.29M-1.36M209.24M122.14M165.56M274.02M-35.55M-11.86M-29.55M131.54M281.34M-565.00K-35.92M
Capital Expenditure2.33M10.44M11.03M6.51M15.53M27.85M39.55M35.53M29.47M24.98M38.36M28.75M24.89M34.09M
Free Cash Flow-15.10M-24.07M-86.13M-26.34M-51.04M-55.81M-60.20M-78.18M-45.70M13.76M-49.91M113.84M-6.13M4.75M
Dividends Paid---000-61.13M20.00M1.30M14.88M18.79M20.09M11.13M
FCF to OCF118.24%176.59%114.69%132.86%143.72%199.61%291.52%183.33%281.65%35.52%432.04%79.84%-32.66%12.24%
Dividend Paid to FCF---0.00%0.00%0.00%--78.19%-43.77%9.44%-29.82%16.51%-327.76%234.01%

Earnings

Report DateAug 6, 2015Nov 5, 2015Feb 25, 2016May 12, 2016Aug 4, 2016Nov 9, 2016Feb 28, 2017May 9, 2017Aug 7, 2017Nov 2, 2017Feb 27, 2018May 9, 2018Aug 7, 2018Nov 6, 2018Feb 26, 2019May 7, 2019Aug 6, 2019Nov 5, 2019Feb 25, 2020May 7, 2020Aug 4, 2020Nov 5, 2020Feb 25, 2021May 5, 2021Aug 4, 2021Nov 3, 2021Feb 23, 2022May 4, 2022Aug 2, 2022Nov 2, 2022Feb 22, 2023May 3, 2023Aug 2, 2023Nov 2, 2023Feb 22, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Feb 20, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 24, 2026May 6, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate-0.28-0.24-0.22-0.20-0.16-0.13-0.20-0.16-0.13-0.08-0.04-0.04-0.04-0.04-0.04-0.33-0.23-0.12-0.04-0.13-0.10-0.05-0.05-0.07-0.03-0.030.01-0.000.050.100.160.190.150.100.150.300.250.340.010.100.080.100.050.05-0.10-0.05
EPS Actual-0.24-0.16-0.05-0.16-0.12-0.11-0.18-0.14-0.13-0.04-0.040.02-0.03-0.04-0.07-0.31-0.26-0.09-0.07-0.14-0.03-0.03-0.01-0.01-0.02-0.030.080.120.100.590.100.210.140.300.230.340.300.04-0.020.06-0.170.050.08-0.02-0.11-
Surprise14.29%33.33%77.27%20.00%25.00%15.38%10.00%12.50%0.00%50.00%0.00%150.00%25.00%0.00%-75.00%6.06%-13.04%25.00%-75.00%-7.69%70.00%40.00%80.00%85.71%33.33%0.00%700.00%6100.00%100.00%490.00%-37.50%10.53%-6.67%200.00%53.33%13.33%20.00%-88.24%-260.00%-40.00%-312.50%-50.00%60.00%-136.83%-10.00%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-market

Key Statistics & Ratios

Market Cap397.97M
Enterprise Value1.26B
Trailing P/E0.00
Forward P/E8.62
PEG Ratio1.93
Price / Sales0.19
Price / Book1.07
EPS-4.37
Book Value3.40
Revenue (TTM)2.10B
Gross Profit (TTM)361.64M
EBITDA61.04M
Profit Margin-24.08%
Operating Margin-1.34%
Return on Equity-66.97%
Return on Assets-0.79%
Shares Outstanding113.06M
Shares Float94.21M
Beta0.84
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 14 analystsTarget 5.77
  • Strong Buy
    9
  • Buy
    4
  • Hold
    1

Ownership Breakdown

Institutions
101.92%
Insiders
3.10%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    10.89M9.63%
  • Cadian Capital Management LP
    10.81M9.57%
  • Morgan Stanley - Brokerage Accounts
    9.08M8.03%
  • UBS Group AG
    8.15M7.21%
  • Rubicon Founders LLC
    5.82M5.14%
  • Engaged Capital LLC
    5.56M4.92%
  • D. E. Shaw & Co LP
    5.11M4.52%
  • Vanguard Capital Management, LLC
    4.87M4.31%
  • State Street Corp
    2.65M2.34%
  • Geode Capital Management, LLC
    2.62M2.32%
  • Maverick Capital Ltd
    2.57M2.28%
  • Rock Springs Capital Management LP
    2.50M2.21%
  • The Goldman Sachs Group Inc
    2.24M1.98%
  • Charles Schwab Investment Management Inc
    1.95M1.72%
  • Jane Street Group LLC
    1.79M1.58%
  • HRT FINANCIAL LLC
    1.73M1.53%
  • Rock Point Advisors, LLC
    1.72M1.52%
  • Kennedy Capital Management Inc
    1.57M1.39%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    3.38M2.99%
  • iShares Russell 2000 ETF
    2.94M2.60%